Efficacy and safety of phage therapy in the management resistant bacterial infections: Systematic review
International Journal of Drug Delivery Technology · 19.06.2026 · 16 (56s)
DOI: 10.25258/ijddt.16.56s.124 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 19.06.2026. Verfasst von Lilian Medina und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Phage therapy is a therapeutic treatment that involves the use of bacteriophages, with significant potential for the treatment of antibiotic-resistant bacterial infections. This method provides a specific and natural alternative that targets only pathogens without harming the beneficial host microbiota.
Objective
To synthetize the available evidence regarding the efficacy and safety of phage therapy compared with antibiotic treatment for infections caused by resistant bacteria. Methodology: A systematic review was conducted based on articles published in major academic databases, including Scopus, PubMed, Springer, and Google Scholar, using Boolean operators and filters specific to each database. A total of 185 articles were identified, of which 19 met the inclusion and exclusion criteria established for this review.
Results
The evaluated randomized trials, case reports, and meta-analyses indicated that phage therapy (topical and intravenous) achieved microbial reduction rates and clinical resolution in a high percentage of patients considered to have conventional therapeutic options. The safety profile was favorable, with very few adverse events, most of which were mild, transient reactions associated with the release of bacterial endotoxins.
Conclusion
The findings of this review suggest that phage therapy is an effective intervention for the management of severe infections caused by resistant bacteria, indicating its potential as a complement or alternative to antibiotic treatments. However, there is a clear need for longitudinal studies to consolidate its integration into formal medical practice.
Zitieren
APA
Medina, L., Pomagualli, A., Champang, J., Conterón, E., Guerra, A., & Herrera, J. (2026). Efficacy and safety of phage therapy in the management resistant bacterial infections: Systematic review. International Journal of Drug Delivery Technology, 16(56s). https://doi.org/10.25258/ijddt.16.56s.124
Vancouver
Medina L, Pomagualli A, Champang J, Conterón E, Guerra A, Herrera J. Efficacy and safety of phage therapy in the management resistant bacterial infections: Systematic review. International Journal of Drug Delivery Technology. 2026;16(56s). doi:10.25258/ijddt.16.56s.124
BibTeX
@article{Medina2026,
author = {Medina, Lilian and Pomagualli, Ana and Champang, Johanna and Conterón, Elizabeth and Guerra, Ana and Herrera, José},
title = {Efficacy and safety of phage therapy in the management resistant bacterial infections: Systematic review},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {56s},
doi = {10.25258/ijddt.16.56s.124}
}
EUVIMED